{"id":475888,"date":"2021-04-14T06:03:26","date_gmt":"2021-04-14T10:03:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/"},"modified":"2021-04-14T06:03:26","modified_gmt":"2021-04-14T10:03:26","slug":"exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/","title":{"rendered":"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope"},"content":{"rendered":"
\n

Talented team and industry-leading lab will help strengthen the company’s sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n MADISON, Wis.<\/span>, April 14, 2021<\/span> \/PRNewswire\/ — Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its\u00a0previously announced acquisition of Ashion Analytics, LLC.<\/a><\/p>\n

\n

\n
\n \"Exact
\n <\/a>\n <\/p>\n<\/p><\/div>\n

“As a leader in cancer testing, we’re committed to providing earlier answers and life-changing treatment guidance to support patients along every step of their cancer journey,” said Kevin Conroy<\/span>, chairman and CEO of Exact Sciences. “With Ashion, we’ve added a talented team, a CLIA-certified and CAP-accredited lab, deep sequencing capabilities, and one of the most comprehensive genomic cancer tests available on the market today with GEM ExTra\u00ae.\u00a0This expertise will be integral in helping us extend our leadership in precision oncology and in serving more patients across the cancer continuum, including therapy selection and minimal residual disease testing.”\u00a0<\/p>\n

Exact Sciences\u00a0and The Translational Genomics Research Institute (TGen) are expanding their multi-year collaboration to further benefit from TGen and City of Hope’s expertise in developing better advanced cancer diagnostics and establishing the clinical evidence necessary to support their adoption. <\/p>\n

\n About Exact Sciences Corp.
<\/b>A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Fueled by the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Alongside its visionary collaborators and in partnership with communities, Exact Sciences unites the best resources to help advance the fight against cancer. For more information, please visit the company’s website at\u00a0www.exactsciences.com<\/a><\/u>, or follow Exact Sciences on Twitter<\/a>, Facebook,<\/a>\u00a0or LinkedIn<\/a>.<\/p>\n

\n About TGen, an affiliate of City of Hope
<\/b>Translational Genomics Research Institute (TGen) is a Phoenix, Arizona<\/span>-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is affiliated with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases.\u00a0This precision medicine affiliation between City of Hope and TGen enables both institutions to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children.\u00a0Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help City of Hope’s patients through efficiency and effectiveness of the translational process. For more information, please visit TGen’s website at\u00a0www.tgen.org<\/a>, or follow TGen on\u00a0<\/b>Facebook<\/a><\/u>,\u00a0LinkedIn<\/a><\/u>\u00a0or\u00a0Twitter @TGen<\/a><\/u>.<\/p>\n

\n About City of Hope
<\/b>City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in\u00a0bone marrow transplantation<\/a>\u00a0and immunotherapy such as\u00a0CAR T cell therapy<\/a>. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies,\u00a0and\u00a0numerous breakthrough cancer drugs<\/a>\u00a0are based on technology developed at the institution. \u00a0Translational Genomics Research Institute (TGen) became a part of City of Hope in 2016.\u00a0AccessHope<\/a>TM<\/sup>, a wholly owned subsidiary, was launched in 2019, dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles<\/span>, with\u00a0additional locations<\/a>\u00a0throughout Southern California<\/span> and in Arizona<\/span>. For more information about\u00a0City of Hope, follow us on\u00a0Facebook<\/a>,\u00a0Twitter<\/a>,\u00a0YouTube<\/a>\u00a0or\u00a0Instagram<\/a>.<\/p>\n

\n Forward-Looking Statement
<\/b>This news release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs or strategies regarding the future.\u00a0 These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions and events to differ materially from those anticipated. You should not place undue reliance on forward-looking statements. There can be no assurance that we will be able to (i) realize the anticipated benefit from the acquisition of Ashion, (ii) successfully commercialize GEM ExTra\u00a0or (iii) successfully develop or commercialize any products or services utilizing the expected collaboration efforts with TGen or City of Hope. Risks and uncertainties that may affect our forward-looking statements are described in the Risk Factors sections of our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.<\/p>\n

\n Exact Sciences Contacts:<\/b>\n <\/p>\n

\n
\n Investor Contact:
<\/u>
\n <\/b>
\n Megan Jones<\/span>
\n
\n mjones@exactsciences.com<\/a>
\n
608-535-8815<\/p>\n

\n
\n Media Contact:
<\/u>
\n <\/b>Steph Spanos\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
sspanos@exactsciences.com<\/a>
608-556-4380<\/p>\n

\n

\n
\n \"(PRNewsfoto\/EXACT
\n <\/a>\n <\/p>\n

\n
\n \"(PRNewsfoto\/EXACT
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope-301268298.html<\/a><\/p>\n

SOURCE EXACT SCIENCES CORP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Talented team and industry-leading lab will help strengthen the company’s sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings PR Newswire MADISON, Wis., April 14, 2021 \/PRNewswire\/ — Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its\u00a0previously announced acquisition of Ashion Analytics, LLC. “As a leader in cancer testing, we’re committed to providing earlier answers and life-changing treatment guidance to support patients along every step of their cancer journey,” said Kevin Conroy, chairman and CEO of Exact Sciences. “With Ashion, we’ve added a talented team, a CLIA-certified and CAP-accredited lab, deep sequencing capabilities, and one of the most comprehensive genomic cancer tests available on the market today with GEM ExTra\u00ae.\u00a0This expertise will be … <\/p>\n

Continue reading “Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-475888","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nExact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Talented team and industry-leading lab will help strengthen the company’s sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings PR Newswire MADISON, Wis., April 14, 2021 \/PRNewswire\/ — Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its\u00a0previously announced acquisition of Ashion Analytics, LLC. “As a leader in cancer testing, we’re committed to providing earlier answers and life-changing treatment guidance to support patients along every step of their cancer journey,” said Kevin Conroy, chairman and CEO of Exact Sciences. “With Ashion, we’ve added a talented team, a CLIA-certified and CAP-accredited lab, deep sequencing capabilities, and one of the most comprehensive genomic cancer tests available on the market today with GEM ExTra\u00ae.\u00a0This expertise will be … Continue reading "Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-14T10:03:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/506016\/Exact_Sciences_Corporation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope\",\"datePublished\":\"2021-04-14T10:03:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/\"},\"wordCount\":903,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/506016\\\/Exact_Sciences_Corporation_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/\",\"name\":\"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/506016\\\/Exact_Sciences_Corporation_Logo.jpg\",\"datePublished\":\"2021-04-14T10:03:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/506016\\\/Exact_Sciences_Corporation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/506016\\\/Exact_Sciences_Corporation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/","og_locale":"en_US","og_type":"article","og_title":"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope - Market Newsdesk","og_description":"Talented team and industry-leading lab will help strengthen the company’s sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings PR Newswire MADISON, Wis., April 14, 2021 \/PRNewswire\/ — Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its\u00a0previously announced acquisition of Ashion Analytics, LLC. “As a leader in cancer testing, we’re committed to providing earlier answers and life-changing treatment guidance to support patients along every step of their cancer journey,” said Kevin Conroy, chairman and CEO of Exact Sciences. “With Ashion, we’ve added a talented team, a CLIA-certified and CAP-accredited lab, deep sequencing capabilities, and one of the most comprehensive genomic cancer tests available on the market today with GEM ExTra\u00ae.\u00a0This expertise will be … Continue reading \"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-14T10:03:26+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/506016\/Exact_Sciences_Corporation_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope","datePublished":"2021-04-14T10:03:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/"},"wordCount":903,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/506016\/Exact_Sciences_Corporation_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/","name":"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/506016\/Exact_Sciences_Corporation_Logo.jpg","datePublished":"2021-04-14T10:03:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/506016\/Exact_Sciences_Corporation_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/506016\/Exact_Sciences_Corporation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exact-sciences-completes-acquisition-of-ashion-analytics-llc-from-the-translational-genomics-research-institute-an-affiliate-of-city-of-hope\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/475888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=475888"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/475888\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=475888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=475888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=475888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}